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Dear Editor,
The recent precision medicine movement has pushed research 
towards the identification of biomarkers that can be used for early 
diagnosis. We designed a pilot study that explores the correlation 
between blood cortisol level (BCL) with depression, depression 
severity and clinical comorbidities in a sample of aged Brazilian 
subjects. We hypothesized that BCL will significantly correlate to 
depression, its severity and with clinical comorbidities in our sample.
Participants were selected from an epidemiological study of 
older residents of the city of Sao Paulo1, which screened positive 
for depression (depression scale-D10-score ≥ 7)2 and a pool of 
outpatients who received treatment for depression. Inclusion 
criteria were 60 years and older, and DSM-IV-TR3 criteria for major 
depressive disorder based on a diagnostic interview by geriatric 
psychiatrists. Controls were 10 adults who were at least 60 years old 
without depression. Exclusion criteria included dementia, other 
organic mental disorder, and DSM-IV-TR-criteria-based diagnoses 
of any psychiatric disorder other than depression. Diagnosis and 
exclusion criteria were assessed with the CAMDEX interview4.
We followed 11 depressed subjects. Seven patients (63.6%) began 
depression after age 60 (late onset depression). Both groups had 
more female subjects (70% of controls and 54.5% of patients). The 
groups were similar in terms of marital status, mini-mental score, 
age and education.
In the initial appointment the subjects were assessed with: Mini 
Mental State Examination (MMSE)5; the CAMCOG version validated 
for the Brazilian population6; Montgomery-Asberg Depression 
Rating Scale (MADRS)7, Cumulative Illness Rating Scale (CIRS)8, 
Bayer Activities of Daily Living Scale (B-ADL) adapted for the 
Brazilian population9, and the Hamilton Rating Scale for Depression 
(HAM-D)10. To ensure that no subjects with incipient dementia 
would be included in the group we applied MMSE, CAMCOG 
and the B-ADL. We were unable to standardize the blood sample 
collection time, but all cases had it collected between 6-10 am 
(controls 6:29-9:42 am, mean = 8:57:55 am, mdn = 8:57 am; depressed 
subjects 6:19-9:52 am, mean = 9:23:44 am, mdn = 9:10 am).
It was found that BCL was significantly higher in the depressed 
aged subjects (p = 0.049, U = 27, Wilcoxon-Mann-Whitney test), and 
correlated significantly with severity of both the depressive symptoms 
(HAM-D: p < 0.001, U = 0; MADRS: p < 0.001, U = 0; B-ADL: p 
< 0.001, U = 10; Wilcoxon-Mann-Whitney test) and the clinical 
comorbidities (CIRS-severity, p = 0.032, U = 25). Finally, depression 
could be predicted by BCL in a regression model (Table 1).
These findings should be taken with caution, as we did not 
standardize the collection time for BCL. Nevertheless, they suggest 
that hypercortisolemic depressed elders comprise a subgroup within 
depressed subjects. Their clinical course may progress with more 
morbidity/comorbidities and functional deficits, as shown by the 
statistically significant relation to all four scales applied. Elevated BCL 
predicts depression (p = 0.037, df = 1, B = 0.34, SE = 0.162, Table 1), 
which suggests that BCL might be involved in the development of 
depression in aged patients. The odds of 1.402 means that for each 
raise of 1 unit (µg/dl) of cortisol level there is 40% increase in risk 
of depression (95% C.I. 1.020 - 1.926).
Table 1. Logistic regression results for the prediction of diagnostic status 
from the BCL 
B S.E. Wald df Sig. Exp(B) 95% C.I.for 
EXP(B)
BCL 0338 0.162 4.333 1 0.037 1.402 1.020 - 1.926
Constant -4.155 2.058 4.076 1 0.044 0.016
BCL: blood cortisol levels; B: the intercept; S.E.: standard error; Wald: Wald chi-square test; 
df: degrees of freedom; Sig.: significance; Exp(B): odds ratio; C.I.: confidence interval.
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